That is, one group including: SSBP1, IFI6 DDT, IFI27, C11orf92, NFKBIA, TNXB, NEAT1 and TFG, was up-regulated in most patients with stage III serous ovarian cancer (Figure 3 and Table 3). Here, IFI6 is linked to ovarian serous adenocarcinoma.